Shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) decreased by 85.08% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) announced topline primary Week 48 data from its Phase 3 D-LIVR study of lonafarnib in two regimens in patients…
Following FDA feedback, Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) will not submit an emergency use authorization (EUA) application of peginterferon lambda for mild-to-moderate COVID-19.…
Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in pre-market trading.